title: Prostate cancer: Charting a course in metastatic castration-sensitive prostate cancer.
authors.affiliation: Genitourinary Malignancies Branch, National Cancer Institute Center for Cancer Research, National Institute of Health, 10 Center Drive, 10/12n226, Bethesda, MD 20892, USA.
authors.forename: Ravi A
authors.initials: RA
authors.lastname: Madan
authors.affiliation: Genitourinary Malignancies Branch, National Cancer Institute Center for Cancer Research, National Institute of Health, 10 Center Drive, 10/12n226, Bethesda, MD 20892, USA.
authors.forename: William L
authors.initials: WL
authors.lastname: Dahut
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000097:blood*; D006801:Humans; D008297:Male; D009360:Neoplastic Cells, Circulating; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D017526:Receptor, IGF Type 1 / Q000097:blood*
chemical_list: D000726:Androgen Antagonists; D000911:Antibodies, Monoclonal; D018931:Antineoplastic Agents, Hormonal; D014408:Biomarkers, Tumor; D017526:Receptor, IGF Type 1; D017430:Prostate-Specific Antigen